-
1
-
-
23944490715
-
Diet, lifestyle, and nonstatin trials: review of time to benefit
-
Denke MA, 2005. Diet, lifestyle, and nonstatin trials: review of time to benefit. The American Journal of Cardiology, 96, 3F–10F.
-
(2005)
The American Journal of Cardiology
, vol.96
, pp. 3F-10F
-
-
Denke, M.A.1
-
2
-
-
85062034904
-
Opinion of the Scientific Panel on Dietetic products, nutrition and allergies (NDA) related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids
-
EFSA (European Food Safety Authority), 2004. Opinion of the Scientific Panel on Dietetic products, nutrition and allergies (NDA) related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids. The EFSA Journal, 81, 1–49.
-
(2004)
The EFSA Journal
, vol.81
, pp. 1-49
-
-
-
3
-
-
85078372341
-
Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL-cholesterol concentrations (ID 621, 1190, 1203, 2906, 2910, 3065) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
-
2069
-
EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2011. Scientific Opinion on the substantiation of health claims related to the replacement of mixtures of saturated fatty acids (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of normal blood LDL-cholesterol concentrations (ID 621, 1190, 1203, 2906, 2910, 3065) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 9(4):2069, 18 pp.
-
(2011)
EFSA Journal
, vol.9
, Issue.4
, pp. 18
-
-
-
4
-
-
84859057023
-
Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol
-
1461
-
EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010. Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal, 8(3):1461, 107 pp.
-
(2010)
EFSA Journal
, vol.8
, Issue.3
, pp. 107
-
-
-
6
-
-
85024103186
-
-
National Academies Press, Washington D.C
-
IoM (Institute of Medicine), 2005. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. National Academies Press, Washington D.C.
-
(2005)
Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids
-
-
-
7
-
-
0042206849
-
Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels
-
Katan MB, Grundy SM, Jones P, Law M, Miettinen T and Paoletti R, 2003. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clinic Proceedings, 78, 965–978.
-
(2003)
Mayo Clinic Proceedings
, vol.78
, pp. 965-978
-
-
Katan, M.B.1
Grundy, S.M.2
Jones, P.3
Law, M.4
Miettinen, T.5
Paoletti, R.6
-
8
-
-
33745607390
-
Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee
-
Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M and Wylie-Rosett J, 2006. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation, 114, 82–96.
-
(2006)
Circulation
, vol.114
, pp. 82-96
-
-
Lichtenstein, A.H.1
Appel, L.J.2
Brands, M.3
Carnethon, M.4
Daniels, S.5
Franch, H.A.6
Franklin, B.7
Kris-Etherton, P.8
Harris, W.S.9
Howard, B.10
Karanja, N.11
Lefevre, M.12
Rudel, L.13
Sacks, F.14
Van Horn, L.15
Winston, M.16
Wylie-Rosett, J.17
-
9
-
-
0038135048
-
Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials
-
Mensink RP, Zock PL, Kester AD and Katan MB, 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition, 77, 1146–1155.
-
(2003)
American Journal of Clinical Nutrition
, vol.77
, pp. 1146-1155
-
-
Mensink, R.P.1
Zock, P.L.2
Kester, A.D.3
Katan, M.B.4
-
10
-
-
65649128173
-
Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils
-
Mozaffarian D and Clarke R, 2009. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. European Journal of Clinical Nutrition, 63 Suppl 2, S22–33.
-
(2009)
European Journal of Clinical Nutrition
, vol.63
, pp. 22-33
-
-
Mozaffarian, D.1
Clarke, R.2
-
11
-
-
0032539162
-
Intensive lifestyle changes for reversal of coronary heart disease
-
(erratum in 1999)., (erratum 281, 1380)
-
Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, Sparler S, Armstrong WT, Ports TA, Kirkeeide RL, Hogeboom C and Brand RJ, 1998 (erratum in 1999). Intensive lifestyle changes for reversal of coronary heart disease. The Journal of the American Medical Association, 280, 2001–2007, (erratum 281, 1380).
-
(1998)
The Journal of the American Medical Association
, vol.280
, pp. 2001-2007
-
-
Ornish, D.1
Scherwitz, L.W.2
Billings, J.H.3
Brown, S.E.4
Gould, K.L.5
Merritt, T.A.6
Sparler, S.7
Armstrong, W.T.8
Ports, T.A.9
Kirkeeide, R.L.10
Hogeboom, C.11
Brand, R.J.12
-
12
-
-
27744603499
-
Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial
-
Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M and Tsai J, 2005. Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. The Journal of the American Medical Association, 294, 2437–2445.
-
(2005)
The Journal of the American Medical Association
, vol.294
, pp. 2437-2445
-
-
Pedersen, T.R.1
Faergeman, O.2
Kastelein, J.J.3
Olsson, A.G.4
Tikkanen, M.J.5
Holme, I.6
Larsen, M.L.7
Bendiksen, F.S.8
Lindahl, C.9
Szarek, M.10
Tsai, J.11
-
13
-
-
38349103679
-
The evidence for dietary prevention and treatment of cardiovascular disease
-
van Horn L, Mc Coin M, Kris-Etherton PM, Burke F, Carson JA, Champagne CM, Karmally W and Sikand G, 2008. The evidence for dietary prevention and treatment of cardiovascular disease. Journal of the American Diet Association, 108, 287–331.
-
(2008)
Journal of the American Diet Association
, vol.108
, pp. 287-331
-
-
van Horn, L.1
Mc Coin, M.2
Kris-Etherton, P.M.3
Burke, F.4
Carson, J.A.5
Champagne, C.M.6
Karmally, W.7
Sikand, G.8
-
15
-
-
3042720873
-
Expert Report: Diet, nutrition and prevention of chronic diseases
-
WHO Technical Report Series. WHO Technical Report Series 916
-
WHO/FAO (World Health Organization/Food and Agriculture Organization), 2003. Expert Report: Diet, nutrition and prevention of chronic diseases. Report of a Joint WHO/FAO Expert Consultation. WHO Technical Report Series. WHO Technical Report Series 916.
-
(2003)
Report of a Joint WHO/FAO Expert Consultation
-
-
|